BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10680643)

  • 1. Effect of DT-TX 30, a combined thromboxane synthase inhibitor and thromboxane receptor antagonist, on retinal vascularity in experimental diabetes mellitus.
    De La Cruz JP; Moreno A; Ruiz-Ruiz MI; Sánchez De La Cuesta F
    Thromb Res; 2000 Feb; 97(3):125-31. PubMed ID: 10680643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction.
    De La Cruz JP; Villalobos MA; Escalante R; Guerrero A; Arrebola MM; Sánchez de La Cuesta F
    Br J Pharmacol; 2002 Dec; 137(7):1082-8. PubMed ID: 12429581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of camonagrel, a selective thromboxane synthase inhibitor, on retinal vascularization in experimental diabetes.
    De La Cruz JP; Moreno A; Ruiz-Ruiz MI; García Campos J; Sánchez de la Cuesta F
    Eur J Pharmacol; 1998 May; 350(1):81-5. PubMed ID: 9683018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats.
    de la Cruz JP; Moreno A; Ruiz-Ruiz MI; García-Campos J; Sánchez de la Cuesta F
    Eur J Pharmacol; 1998 Oct; 360(1):37-42. PubMed ID: 9845270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS; Wharton KA; White BP; Lumley P
    Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary pharmacology of DT-TX 30 SE, a potent selective combined thromboxane synthetase inhibitor and receptor antagonist, in guinea pigs.
    Meade CJ; Muacevic G; Ward P; Soyka R
    Jpn J Pharmacol; 1996 Jun; 71(2):119-27. PubMed ID: 8835638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of clopidogrel and ticlopidine on experimental diabetic ischemic retinopathy in rats.
    De La Cruz P; Arrebola M; González-Correa A; Martinez-Cerdán E; Moreno A; de la Cuesta FS
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):204-10. PubMed ID: 12595963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DTTX30, a combined thromboxane receptor antagonist and thromboxane synthetase inhibitor, prevents coronary thrombosis in anesthetized dogs.
    Guth BD; Müller TH
    Basic Res Cardiol; 1997 Jun; 92(3):181-90. PubMed ID: 9226103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aspirin on prostanoids and nitric oxide production in streptozotocin-diabetic rats with ischemic retinopathy.
    De La Cruz P; Guerrero A; Paniego J; Arranz I; Moreno A; Sánchez De La Cuesta F
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):96-101. PubMed ID: 11819026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
    J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic properties of FK070 (KDI-792), a novel thromboxane receptor antagonist/thromboxane synthetase inhibitor, after single and multiple oral administrations to healthy volunteers.
    Uematsu T; Kosuge K; Umemura K; Nakano M; Terakawa M; Nakashima M
    J Pharm Pharmacol; 1996 Apr; 48(4):380-5. PubMed ID: 8794987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
    Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C
    J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
    Gomi T; Ikeda T; Ishimitsu T; Uehara Y
    Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, on retinal vascularity in diabetic rats.
    De La Cruz JP; Jebrouni N; López-Villodres JA; Muñoz-Marín J; Guerrero A; González-Correa JA
    Diabetes Metab Res Rev; 2012 Feb; 28(2):132-8. PubMed ID: 22423383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
    Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostacyclin-thromboxane balance and retinal vascular pattern in rats with experimentally induced diabetes.
    Moreno A; De La Cruz JP; Garcia Campos J; Sanchez De La Cuesta F
    Can J Ophthalmol; 1995 Apr; 30(3):117-23. PubMed ID: 7627895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
    Dale J; Thaulow E; Myhre E; Parry J
    Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZD9583, an orally effective thromboxane A2 synthase inhibitor and receptor antagonist with a sustained duration of action in rat and dog.
    Brownlie RP; Brownrigg NJ; Butcher HM; Garcia R; Jessup R; Lee VJ; Tunstall S; Wayne MG
    J Pharm Pharmacol; 1997 Feb; 49(2):187-94. PubMed ID: 9055193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ditazol on the vascular retinal pattern in experimental diabetes in rats.
    Moreno A; De La Cruz JP; Mérida F; García Campos J; Sánchez de la Cuesta F
    Haemostasis; 1995; 25(4):166-71. PubMed ID: 7557655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.